Several pathophysiological conditions, including nephrotic syndrome, are characterized by increased renal activity of the epithelial Na + channel (ENaC). We recently identified plasmin in nephrotic urine as a stimulator of ENaC activity, and undertook this study to investigate the mechanism by which plasmin stimulates ENaC activity. Cy3-labeled plasmin was found to bind interacts with GPI-anchored prostasin, which leads to cleavage of the γ-subunit and activation of ENaC, while at higher concentrations, plasmin directly activates ENaC.
Introduction
In the aldosterone-responsive epithelial cells of kidney, the epithelial sodium channel (ENaC) establishes the rate-limiting step in transepithelial sodium transport, which is of critical importance in the control of sodium balance, blood volume, and blood pressure (45) . The channel is composed of three homologous subunits α, β, γ, (8) and each subunit has intracellular N-and C-termini, two transmembrane domains, and a large extracellular domain (18) . The activity of ENaC is regulated by hormones, e.g. aldosterone (2, 28, 30 ) and vasopressin (13) , and local factors, e.g. sodium concentration, pH, and intracellular Ca 2+ (34) . Moreover, within the last decade serine proteases have also been shown to activate ENaC (42) . Serine proteases comprise a large family of proteolytic enzymes that are involved in a plethora of physiological and pathophysiological functions, ranging from digestive proteases that breakdown food proteins to proteases that recognize specific cleavage site or even single proteins (20) . The exact mechanism by which serine protease activates ENaC is still not resolved (37) ; however, cleavage of the extracellular domain of the α and γ subunit seems to be a critical step in the proteolytic activation of ENaC (24, 36) . The cleavages of the extracellular domain may lead to release of an inhibitory peptide and an increase in the open-probability (5, 24) . A fraction of the ENaC subunits are cleaved within the biosynthesis pathway by the intracellular protease furin (22, 23), giving rise to both noncleaved and cleaved ENaC channels in the plasma membrane (23) . Thus, at the plasma membrane, a pool of noncleaved channels are present, which can be activated by extracellular serine proteases (1, 6, 7, 11, 42, 43) . Several extracellular serine protease have been shown to activate ENaC in vitro through cleavage of the γ subunit, including channel activating protease 1 (CAP1/prostasin) (42) , trypsin (42) , chymotrypsin (11) , neutrophil elastase (6) , and plasmin (35, 41) with prostasin as the relevant candidate under physiological conditions (46) . 3 Moreover, proteolytic ENaC activation may be a means of regulating sodium reabsorption in kidney in vivo, since rats fed a 1% sodium diet express both full length and cleaved γENaC at the plasma membrane, while Na-depleted or aldosterone-treated rats mainly express the cleaved subunit (16) .
We recently identified the serine protease plasmin as an ENaC activator in urine from rats and humans with nephrotic syndrome (41) . Plasmin-stimulated ENaC activity could contribute to the observed renin-angiotensin-aldosterone independent primary sodium retention characteristic for the disease. Plasmin was shown to stimulate ENaC activity in expression systems, in collecting duct cells and and to cleave purified γ-subunit (35, 41) , leading to the release of an inhibitory peptide from the extracellular domain (41) . Thus, this study was undertaken to investigate potential interaction targets and mechanisms by which plasmin stimulates ENaC activity in the collecting duct cell line M-1. 
Materials and Methods

Cell culture
Biotin-label transfer experiment
Interaction partners of plasmin were identified using ProFound Sulfo-SBED Biotin Label
Transfer kit (Pierce, Herlev, Denmark) as described by the manufacturer. Briefly, plasmin was labeled with the biotinylated cross-linker sulfo-SBED. Labeled plasmin was added to confluent M-1 cells grown in 6-well plates (Nunc) and incubated for 5 min at 37 °C/5% CO 2 . The crosslinker was activated by UV-illumination for 15 min with cells incubated on ice. Cells were lysed and biotinylated proteins were precipitated with streptavidin-agarose. The pelleted proteins were reduced and analyzed by immunoblotting.
siRNA-mediated knock-down
M-1 cells were transfected with siRNA using DharmaFECT1 (Dharmacon, Herlev, Denmark) as previously described (41) . Prostasin was knockeddown using 50 nM ON-TARGET plus PRSS8
siRNA (cat# L-053718-01, Dharmacon). For negative control, cells were transfected with Silencer® Negative Control (cat# AM4611, Ambion, Naerum, Denmark).
PI-PLC was purchased from Invitrogen and used at a concentration of 0.1 U/ml for at least 60 min prior to experiments. Recombinant GST-tagged prostasin was purchased from Abnova (Taiwan) and prostasin cleavages was assayed as described (32).
Reverse transcriptase-quantitative PCR 5 RNA was extracted from M-1 cells in accordance with the manufacturer's instruction (Qiagen Mini Kit, Qiagen, Ballerup, Denmark) and reverse transcribed using iScript cDNA synthesis kit (Biorad, Copenhagen, Denmark). Prostasin cDNA levels were measured using mouse prostasin primers. Prostasin cDNA levels were normalized to 18S cDNA. All reactions were run with IQ SYBR Green Supermix (Biorad) on an Mx3000P (Stratagene, La Jolla, CA) thermocycler.
Urine from rats with puromycin aminonucleoside (PAN)-induced nephrotic syndrome
PAN nephrosis in rats was induced and urine was collected as previously described (3, 41) . The experiments were approved by the Danish Animal Experiments Inspectorate under the Department of Justice (171001-096).
Whole-cell patch clamp of single M-1 cells
Whole-cell patch clamp was carried out as previously described (41 amiloride at a final concentration of 100 µM to the apical bath at the end of the experiment.
Laser-scanning confocal microscopy with plasmin-Cy3
The fluorophore Cy3 (Amersham Bioscience Hillerod, Denmark) was coupled to rat plasmin Confocal laserscanning fluorescence microscopy (Olympus FV1000, Hamburg, Germany) was performed using a ×20 (numerical aperture, 0.5) Olympus water immersion objective. The scanning area was set to 512 x 512 pixels with and without internal zoom. Full-frame imaging was performed at 1 Hz using excitation from a laser at 559 nm with fluorescence monitored through a 570-670 nm band pass (AOTF). Laser power was adjusted (transmissivity 8%;
photomultiplier tube voltage 450-550 V) to obtain images with a mean intensity of 150 arbitrary intensity units (range 100-4,095). This ensured fluorescence acquisition over the full dynamic range of Plasmin-Cy3 without pixel saturation or excessive photobleaching.
Generation and purification of monoclonal antibodies. 
Statistics
Results are presented as mean ± standard error of the mean (SEM) and n is the number of observations. SigmaPlot 9.0 (Systat Software, Chicago, IL) was used for data analysis and data fitting. P<0.05 was considered significant.
Results
Plasmin interacts with prostasin.
Cy3 
Involvement of prostasin in plasmin-stimulated ENaC activity.
We next investigated whether prostasin was functionally involved in plasmin-stimulated ENaC activity. To test if a GPI-anchored protein is involved in plasmin-stimulated ENaC activity, monolayers of M-1 cells were treated with or without PI-PLC before measuring the short-circuit currents in response to different plasmin concentrations. The PI-PLC treated monolayers showed a reduced plasmin-stimulated current compared to control monolayers at plasmin concentrations of 1.3 to 3.90 µg/ml (Figure 3a) . However, there was no difference between monolayers treated with or without PI-PLC when using the high plasmin concentration (30 µg/ml) (Figure 3a) .
Moreover, no differences in baseline, trypsin, and amiloride-insensitive short-circuit currents in monolayers treated with or without PI-PLC were detected (Figure 3b ). These data indicate that at least in the range of plasmin concentrations between 1-4 µg/ml, a GPI-anchored protein is necessary for the plasmin-stimulated ENaC activity, while at higher concentrations a direct interaction with ENaC is more likely. 12 The functional significance of prostasin knockdown was tested using the whole-cell configuration of the patch-clamp technique. Single M-1 cells transfected with control siRNA (50 nmol/L) showed a significant increase in whole-cell current after stimulation with plasmin (10 µg/ml)or nephrotic urine (Figure 3c, d ), which we previously have shown to be mediated by ENaC (41). However, siRNA-mediated knockdown of prostasin blocked the ability of plasmin (10 µg/ml) and nephrotic rat urine to stimulate ENaC current in M-1 cells (Figure 3c,d ). This suggests that prostasin is involved in plasmin-stimulated ENaC activity.
Prostasin and γENaC are colocalized in M-1 cells
Attempts to detect endogenous prostasin using immunofluorescence were unsuccessful and therefore we expressed human prostasin with a C-terminal FLAG-tag in M-1 cells. We found 
Plasmin induces prostasin-dependent release of γENaC inhibitory peptide
We (41) It is well known that cascades of sequential activation of serine prosteases drive processes such as blood coagulation, complement fixation, and fibrinolysis (20) . Prostasin is a downstream target in a proteolytic cascade that involves matriptase in a process regulating terminal epidermal differentiation (27, 32) . However, the finding that plasmin-stimulated ENaC activity involves a serine protease cascade with prostasin is novel. Our data cannot rule out that a serial proteolytic action of prostasin and plasmin on γENaC is responsible for the observed effect. However, ENaC is fully activated by furin-and prostasin-dependent release of the inhibitory peptide from the γ subunit (4), and the proposed cleavage sites for prostasin and plasmin (at high concentrations)
are located adjacent to each other (35) . Thus, a mechanism involving sequential prostasin-and plasmin-dependent γENaC cleavage seems less likely. Since prostasin is expressed in collecting ducts in vivo (46) , this observation may be relevant to understand the pathophysiological ENaC-15 dependent NaCl retention associated with proteinuric diseases such as nephrotic syndrome (41) and anti-Thy1 glomerulonephritis (17) . Proteolytic processing of ENaC blunts Na + selfinhibition (10, 39) by releasing the inhibitory peptide form the γ-subunit. The inhibitory peptide is flanked by cleavage sites for furin, on one side, and prostasin and plasmin (at a high concentration) on the other.
The set of data indicate that plasmin interacts with GPI-anchored prostasin. In agreement with previous observations (9), we found that the major pool of endogenously expressed prostasin in M-1 cells was GPI-anchored. In the low range of the tested plasmin concentrations (below 10 μg/ml), we found that intact GPI-anchored proteins and prostasin expression was necessary for stimulation of ENaC, whereas at higher concentrations the plasmin-stimulation was independent of GPI-anchored proteins. GPI-anchored proteins are mainly located in microdomains termed lipid rafts (38) , which have also been shown to contain endogenous ENaC (21) . This is in agreement with our finding that prostasin and γENaC are colocalized. The anchoring of prostasin in lipid rafts appears to be important for its ENaC activating function, since mutation of the GPIanchored motif in prostasin leaves it unable to activate ENaC (44) . Thus, at low plasmin concentration, lipid rafts could provide an environment, which favors the plasmin-stimulated ENaC activity through prostasin. Passero et al.(35) have observed an additional ENaC cleavage product when using plasmin at a high concentration (27 µg/ml), which could be abolished by mutating a site (γK194A) distal to the prostasin cleavage site. This is in agreement with our data and suggests that at high concentrations, plasmin interacts and cleaves γENaC directly. Similar to this observation, trypsin-stimulated ENaC activity was not dependent on prostasin. In accord, trypsin interacted with several molecules in M-1 cells larger than prostasin, with a size that ranged from 50-90 kDa. The two prominent trypsin-interacting molecules of sizes around 80 and 16 90 kDa might be speculated to be the γ subunit of ENaC (19) . Although the present data show that prostasin is involved in plasmin-stimulated ENaC activation, we cannot rule out that there exist further intermediate steps between prostasin and ENaC and other techniques with higher spatial resolution, e.g. fluorescence resonance energy transfer, should be used to resolve this issue.
The (patho)physiological consequences of these findings remain elusive at present. Recently, we have shown that plasmin in nephrotic urine from humans and rats activates ENaC (41) . Based on a serine protease activity assay, we have estimated a plasmin concentration of 10-15 µg/ml in urine from puromycin aminonucleoside-induced nephrotic syndrome in rat at the peak of proteinuria (not shown). Thus, the prostasin-dependent step in plasmin-stimulated ENaC activity would probably play a minor role in sodium retention at the peak of proteinuria. However, human nephrotic urine displayed a much lower serine protease activity compared to rat urine from the PAN nephrotic model (41) , suggesting that ENaC activation and sodium retention in nephrotic patients could be prostasin-dependent. Moreover, the proteinuria in nephrotic patients is at the extreme of the spectrum and most clinical proteinuric conditions exhibit a lower degree of proteinuria.
Recent data show that the γ subunit of ENaC exists at the cell surface with smaller molecular size than full-length, depending on SGK1 and sodium status (14) such that Na-depletion increases the cleaved form several times at the membrane surface (16) . A recent study showed that γENaC subunit appears to be proteolytic processed in proteinuric glomerulonephritis (17) .
Thus, proteolytic modification of γENaC appears to occur under physiological and pathophysiological conditions. The dominance of cleaved γENaC at the cell surface in sodium depleted states is consistent with the observation that prostasin expression is stimulated by 17 aldosterone (31, 33) . Intriguingly, camostat mesilate has been shown to be an inhibitor of prostasin activity (12, 29) that reduced blood pressure and renal injury in salt-sensitive rats (29) .
In patients with advanced diabetic nephropathy camostate reduced edema volume (25) . Although indirect, these data are in accord with a role of prostasin to promote sodium retention in vivo.
Perspectives and Significance
The present study provides evidence that plasmin-stimulated ENaC activity depends on GPIanchored prostasin at low plasmin concentration, whereas the activation is prostasin-independent at high plasmin concentrations ( Figure 5 ). The study identifies prostasin as a potential drug target in diseases with proteinuria and abnormal activation of ENaC.
Nephrotic syndrome is at one extreme of an array of proteinuric conditions. Several human diseases e.g. other primary kidney disease, diabetes mellitus, hypertension and preeclampsia are characterised by microalbuminuria (or proteinuria) and sodium retention. Thus, it is of interest to establish if tubular formation of prostasin-dependent plasmin-stimulated ENaC activation may contribute to sodium retention in these conditions. n siRNA Prostasin Figure 5 
